Rheumatoid Arthritis Response to Methotrexate

Juan Carlos Nieto

Status: Unknown

Conditions: Rheumatoid Arthritis

Treatments: Drug: Methotrexate

Study type: Observational

Funder types: Other; Industry

Identifiers

NCT03535519

Reuma-01-2017

Details and patient eligibility

About

Observational and prospective study of the ultrasound response to methotrexate in rheumatoid arthritis patients who started methotrexate

Full description

• Rheumatoid arthritis patients with active disease who start subcutaneous methotrexate by their rheumatologist prescription methotrexate will be included.
• Patients will participate in a prospective and observational study in which the response to methotrexate will be assessed by ultrasound (US) of joints and tendons.
• The main objective of the study is the change in B mode and Doppler mode US after 24 weeks of methotrexate treatment.

Enrollment: 50 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Active rheumatoid arthritis fulfilling EULAR criteria.
• Prescription of methotrexate by a rheumatologist.
• Informed consent signed by the patient.

Exclusion criteria

• None